GreyRigge Associates
Biotechnology Research • 
Ashridge Manor, Wokingham, United Kingdom • 1-10 Employees
Company overview
| Headquarters | Ashridge Manor, Wokingham, Berkshire RG40 5RB, GB |
| Phone number | +441189791169 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Process Development, Biopharma, Project Management, CMC, Assay Development, Quality Assurance, Validation, Therapeutics, Vaccines, Biologics, Stability, Virus, Design Of Experiments, QbD, Antibody Drug Conjugates, Advanced Therapies, Monoclonal Antibodies, Strategic Planning And Due Diligence, Cmc Regulatory, Cell Based Bioassay |
| Founded | 2010 |
| Employees | 1-10 |
| Socials |
Key Contact at GreyRigge Associates
Samantha Dowse
Principal Consultant/ Director
GreyRigge Associates Email Formats
GreyRigge Associates uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@greyrigge.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@greyrigge.com | 50% |
{first name}.{last name} | john.doe@greyrigge.com | 50% |
About GreyRigge Associates
GreyRigge Associates is a global biotech partner delivering consultancy, management expertise and training across the entire product development journey. Our extensive biopharmaceutical industry experience and pragmatic, agile approach enables transformational success by accelerating our clients’ medicines to market. We specialise in early-stage product development through to late-stage development and, ultimately, product launch. Our consulting services cover: - CMC & Manufacturing - Assays & Quality Control - QA, Auditing & Regulatory Affairs - Programme & CDMO Management - Strategic Planning & Due Diligence - Formulation Development & Stability - Preclinical, Non-clinical & Toxicology - Clinical Development & Monitoring Recent projects: - CMC process & formulation development, including CDMO(s) management for peptides, therapeutic proteins, live vaccines and a novel recombinant protein - Analytical development & Stability management for monoclonal antibodies and antibody fragments, a bispecific antibody domain, therapeutic proteins, live vaccines, peptides, antibody drug conjugates (ADCs) and CGT from stem cells - CMC, SDM and MSAT regulatory support for mAb biosimilars, providing external review of the process and analytical characterisation, validation and other CMC BLA supporting activities - CDMO selection & Management and process development - Extractables & Leachables risk assessment activity - Cell-based bioassay development for an ADC - Cell banking for a vaccine platform We help: - Biopharmaceuticals looking for consultancy, programme management, extra team support or training - Investors looking at novel assets requiring support to investigate opportunities, valuation and due diligence We love working with collaborative and supportive fellow experts, so if you are an experienced consultant open to rewarding freelance opportunities, then contact us. GreyRigge Associates: Experts | Transformative | Agile .
GreyRigge Associates revenue & valuation
| Annual revenue | $855,550 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
GreyRigge Associates has 5 employees across 3 departments.
Departments
Number of employees
Funding Data
GreyRigge Associates has never raised funding before.
GreyRigge Associates Tech Stack
Discover the technologies and tools that power GreyRigge Associates's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Tag managers
Reverse proxies
Form builders
Programming languages
Miscellaneous
Security
Blogs
SpainFrequently asked questions
4.8
40,000 users
